1350 J. Am. Chem. Soc., Vol. 122, No. 7, 2000
Shuto et al.
14 H), 6.15, 6.13 (each dd, each 0.5 H, J ) 19.8, 14.8 Hz), 6.06, 6.05
(each dd, each 0.5 H, J ) 14.8, 4.2 Hz), 5.77, 5.76 (each dd, each 0.5
H, J ) 19.8, 4.2 Hz), 4.69-4.66 (m, 2 H), 3.21-3.16 (m, 1 H), 2.81
(d, 1 H, J ) 16.5 Hz), 0.32, 0.31 (each s, each 1.5H); 13C NMR (100
MHz, CDCl3) δ 141.2, 140.9, 136.0, 135.4, 135.0, 134.61,134.56, 133.9,
129.7, 129.54, 129.52, 128.9, 127.71, 127.65, 127.59, 127.56, 126.7,
125.5, 124.9, 79.8, 54.7, 54.6, 40.69, 40.67, -3.06, -3.09; EI HRMS
calcd for C24H24OSeSi 436.0760, found 436.0756 (M+).
Radical Reaction of 11 for the Preparation of 8a and 8b. A stirred
solution of 11 (2.18 g, 5.01 mmol) and (Bu3Sn)2 (250 µL, 500 µmol)
in benzene (25 mL) was irradiated with a high-pressure mercury lamp
(300 W) at room temperature for 25 h. The solvent was evaporated,
and the residue was purified by silica gel column chromatography (Et2O/
hexane, 1:20) to give a mixture of 8a, 8b, 8c, and 8d (1.23 g, 56%,
8a:8b:8c:8d ) 48:35:9:8, based on its 1H NMR) as an oil. From a part
of the oil (100 mg), 8a (38 mg, 22%), 8b (29 mg, 16%), 8c (5 mg,
3%), and 8d (4 mg, 2%) were obtained in a pure form, respectively,
by preparative HPLC separation (AcOEt/hexane, 1:30).
silica gel column chromatography (Et2O/hexane, 1:50) to give a mixture
of 9a, 9b, 10a, and 10b (63 mg, 44%, 9a:9b:10a:10b ) 22:13:63:2,
1
based on H NMR) as an oil. From the mixture, 9a (10 mg, 7%), 9b
(4 mg, 3%), 10a (28 mg, 20%), and 10b (1 mg, 0.7%) were obtained
in a pure form, respectively, by preparative HPLC separation (AcOEt/
hexane, 1:100).
[2R*,3R*,4R*,5S*]-Indano[1,2-d]-2,3-dimethyl-2-phenyl-1,2-
oxasilolane (9a): 1H NMR (500 MHz, CDCl3) δ 7.56-7.19 (m, 9
H), 5.13 (dt, 1 H, J ) 5.3, 2.2 Hz), 3.34 (t, 1 H, J ) 4.4 Hz), 3.21 (dd,
1 H, J ) 16.6, 2.2 Hz), 3.14 (dd, 1 H, J ) 16.6, 2.0 Hz), 1.65 (dq, 1
H, J ) 7.8, 3.5 Hz), 1.04 (d, 3 H, J ) 7.8 Hz), -0.02 (s, 3 H); NOE
(CDCl3, 400 MHz) irradiated Si-Me, observed H-3 (0.8%); irradiated
H-3, observed H-4 (2.9%); irradiated 3-Me, observed H-4 (2.4%); the
assignments were in agreement with the H-H COSY spectrum;13C
NMR (100 MHz, CDCl3) δ 144.6, 141.3, 135.4, 133.8, 129.7, 127.7,
127.0, 126.5, 125.2, 124.4, 82.2, 57.6, 41.5, 23.8, 15.9, -1.4; EI HRMS
calcd for C18H20OSi 280.1283, found 280.1293 (M+). Anal. Calcd for
C18H20OSi: C, 77.09; H, 7.19. Found: C, 77.00; H, 7.26.
[2S*,3R*,4R*,5S*]-Indano[1,2-d]-2,3-dimethyl-2-phenyl-1,2-
oxasilolane (9b): 1H NMR (500 MHz, CDCl3) δ 7.25-6.96 (m, 9
H), 5.07 (dt, 1 H, J ) 5.4, 2.4 Hz), 3.34 (t, 1 H, J ) 4.5), 3.21 (dd, 1
H, J ) 16.6, 5.4 Hz), 3.15 (dd, 1 H, J ) 16.6, 2.1 Hz), 1.69 (dq, 1 H,
J ) 7.8, 3.5 Hz), 1.33 (d, 3 H, J ) 7.9 Hz), 0.46 (s, 3 H); NOE (CDCl3,
400 MHz) irradiated Si-Me, observed 3-Me (1.0%), H-4 (0.2%), H-5
(0.3%); irradiated H-3, observed H-4 (3.4%); irradiated 3-Me, observed
H-4 (2.9%); the assignments were in agreement with the H-H COSY
spectrum;13C NMR (100 MHz, CDCl3) δ 144.4, 141.2, 136.2, 133.3,
129.3, 127.3, 127.0, 126.5, 125.0, 124.7, 81.9, 57.8, 41.2, 23.6, 15.7,
-4.4; EI HRMS calcd for C18H20OSi 280.1283, found 280.1303 (M+).
[2R*,5R*,6S*]-Indano[1,2-e]-2-methyl-2-phenyl-1,2-oxasilinane
(10a): 1H NMR (500 MHz, CDCl3) δ 7.63-7.17 (m, 9 H), 4.88 (ddd,
1 H, J ) 5.8, 3.7 Hz), 3.19-3.14 (m, 2 H), 3.03 (dd, 1 H, J ) 16.1,
3.6 Hz), 2.26-2.15 (m, 2 H), 1.00-0.89 (m, 2 H), 0.18 (s, 3 H);13C
NMR (125 MHz, CDCl3) δ 143.9, 141.6, 138.1, 133.3, 129.6, 127.9,
126.7, 126.4, 125.0, 123.9, 77.1, 47.3, 41.8, 21.9, 7.7, -1.0; EI HRMS
calcd for C18H20OSi 280.1283, found 280.1296 (M+). Anal. Calcd for
C18H20OSi: C, 77.09; H, 7.19. Found: C, 77.28; H, 7.28.
[2R*,3R*,4R*,5S*]-Indano[1,2-d]-2-methyl-2-phenyl-3-(phenyl-
selenomethyl)-1,2-oxasilolane (8a): 1H NMR (500 MHz, CDCl3) δ
7.58-7.00 (m, 14 H), 5.13 (ddd, 1 H, J ) 5.3, 1.8 Hz), 3.85 (dd, 1 H,
J ) 4.4, 3.4 Hz), 3.22 (dd, 1 H, J ) 16.6, 5.3 Hz), 3.14 (dd, 1 H, J )
16.6 Hz), 2.92 (dd, 1 H, J ) 12.2, 6.8 Hz), 2.89 (dd, 1 H, 12.2, 10.7
Hz), 1.82 (ddd, 1 H, J ) 10.3, 6.8, 3.0 Hz), 0.00 (s, 3 H); NOE (CDCl3,
400 MHz) irradiated Si-Me, observed H-3 (0.8%); irradiated H-3,
observed H-4 (3.3%); the assignments were in agreement with the H-H
COSY spectrum; 13C NMR (100 MHz, CDCl3) δ 144.0, 141.2, 134.4,
133.9, 133.1, 130.1, 130.0, 129.0, 128.0, 127.1, 126.9, 126.6, 125.1,
124.3, 82.1, 55.0, 41.5, 31.1, 30.4, -1.1; EI HRMS calcd for C24H24-
OSeSi 436.0760, found 436.0766 (M+). Anal. Calcd for C24H24OSeSi:
C, 66.19; H, 5.55. Ffound: C, 66.02; H, 5.64.
[2S*,3R*,4R*,5S*]-Indano[1,2-d]-2-methyl-2-phenyl-3-(phenyl-
selenomethyl)-1,2-oxasilolane (8b): 1H NMR (500 MHz, CDCl3) δ
7.52 (m, 14 H), 5.05 (ddd, 1 H, J ) 5.0, 1.7 Hz), 3.83 (m 1 H), 3.38
(dd, 1 H, J ) 11.8, 6.2 Hz), 3.22 (dd, 1 H, J ) 11.7, 4.9 Hz), 3.20-
3.15 (m, 2 H), 1.92 (ddd, 1 H, J ) 11.4, 6.2, 2.4 Hz), 0.57 (s, 3 H);
NOE (CDCl3, 400 MHz) irradiated SiMe, observed 3-CH2Se (0.9%,
0.5%), H-5 (0.3%); irradiated H-3, observed H-4 (3.8%); the assign-
ments were in agreement with the H-H COSY spectrum; 13C NMR
(100 MHz, CDCl3) δ 143.8, 141.2, 135.3, 133.4, 133.2, 129.8, 129.5,
129.1, 127.4, 127.1, 127.0, 126.6, 125.0, 124.7, 81.7, 55.5, 41.3, 31.0,
30.5, -4.1; EI HRMS calcd for C24H24OSeSi 436.0760, found 436.0753
(M+). Anal. Calcd for C24H24OSeSi: C, 66.19; H, 5.55. Found: C,
66.18; H, 5.70.
[2R*,3S*,4R*,5S*]-Indano[1,2-d]-2-methyl-2-phenyl-3-(phenyl-
selenomethyl)-1,2-oxasilolane (8c): 1H NMR (500 MHz, CDCl3) δ
7.58-7.20 (m, 14 H), 4.95 (ddd, 1 H, J ) 4.9, 2.0 Hz), 3.91 (dd, 1 H,
J ) 7.8, 5.0 Hz), 3.62 (dd, 1 H, J ) 11.4, 9.0 Hz), 3.33 (dd, 1 H, J )
11.4, 9.0 Hz), 3.15 (dd, 1 H, J ) 16.7, 4.9 Hz), 3.13 (dd, 1 H, 16.6,
1.1 Hz), 2.19 (ddd, 1 H, J ) 9.1 Hz), 0.04 (s, 3 H); NOE (CDCl3, 400
MHz) irradiated SiMe, observed 3-CH2Se (0.4%, 0.5%); irradiated H-3,
observed H-4 (10.4%), H-6 (2.1%); the assignments were in agreement
with the H-H COSY spectrum; 13C NMR (100 MHz, CDCl3) δ 142.8,
141.3, 136.0, 133.7, 132.7, 130.1, 130.0, 129.0, 127.8, 127.2, 126.9,
126.4, 126.2, 125.5, 82.6, 52.2, 41.7, 31.2, 26.4, -3.9.
[2S*,3S*,4R*,5S*]-Indano[1,2-d]-2-methyl-2-phenyl-3-(phenyl-
selenomethyl)-1,2-oxasilolane (8d): 1H NMR (500 MHz, CDCl3) δ
7.48-6.87 (m, 14 H), 4.89 (ddd, 1 H, J ) 4.7, 4.3 Hz), 3.86 (dd, 1 H,
J ) 7.9, 4.5 Hz), 3.53 (dd, 1 H, J ) 11.2, 6.5 Hz), 3.22 (d, 1 H, J )
16.6 Hz), 3.17 (dd, 1 H, J ) 16.6, 4.7 Hz), 3.10 (dd, 1 H, J ) 10.8
Hz), 2.18 (ddd, 1 H, J ) 9.6, 7.8 Hz), 0.57 (s, 3 H); NOE (CDCl3, 400
MHz) irradiated Si-Me, observed H-3 (1.3%); irradiated H-3, observed
H-4 (10.0%), H-5 (2.8%); the assignments were in agreement with the
H-H COSY spectrum; 13C NMR (100 MHz, CDCl3) δ 143.0, 141.5,
134.1, 133.8, 132.7, 130.0, 129.5, 129.1, 127.3, 127.2, 126.9, 126.5,
126.3, 125.4, 82.5, 52.9, 41.4, 32.8, 26.7, -1.0.
[2S*,5R*,6S*]-Indano[1,2-e]-2-methyl-2-phenyl-1,2-oxasilinane
(10b): 1H NMR (500 MHz, CDCl3) δ 7.35-7.16 (m, 9 H), 4.93 (ddd,
1 H, J ) 6.0, 4.5 Hz), 3.21 (dd, 1 H, J ) 12.3, 6.0 Hz), 3.14 (dd, 1 H,
J ) 16.0, 6.0 Hz), 2.98 (dd, 1 H, J ) 16.0, 4.3 Hz), 2.22-2.18 (m, 2
H), 1.04 (ddd, 1 H, J ) 14.3, 8.3, 6.0 Hz), 0.77 (ddd, 1 H, J ) 14.6,
8.1, 5.6 Hz), 0.43 (s, 3 H);13C NMR (125 MHz, CDCl3) δ 143.8, 141.5,
133.3, 129.5, 127.7, 126.7, 126.5, 125.0, 124.0, 77.2, 47.2, 41.4, 22.2,
8.3, -1.7; EI HRMS calcd for C18H20OSi 280.1283, found 280.1270
(M+). Anal. Calcd for C18H20OSi: C, 77.09; H, 7.19. Found: C, 77.08;
H, 7.34
1
Radical Reactions of 8a and 8b and H NMR Analysis of the
Products. To a solution of 8a or 8b (22 mg, 0.051 mmol) in benzene
(5 mL) at 80 °C was added a solution of Bu3SnH (60 µL, 0.22 mmol)
and AIBN (5 mg, 0.03 mmol) in benzene (5 mL) slowly over a 4 h
period. The solvent was evaporated, and the residue was dissolved in
1
CDCl3 and its H NMR spectrum (500 MHz) was measured.
(()-Ethyl trans-4-(tert-Butyldiphenylsilyloxy)-2-butenoate (16).
A mixture of 15 (10.0 g, 69.4 mmol) and BH3 (1 M in THF, 70 mL,
70 mmol) in THF (30 mL) was stirred at room temperature for 12 h.
After aqueous AcOH (50%, 2 mL) was added, the solvent was
evaporated, and the residue was partitioned between AcOEt and aqueous
NaHCO3 (saturated). The organic layer was washed with brine, dried
(Na2SO4), and evaporated to give an oil. A mixture of the resulting
oil, imidazole (6.81 g, 100 mmol), and TBDPSCl (13.0 mL, 50.0 mmol)
in DMF (100 mL) was stirred at room temperature for 3 h. Et2O and
water were added, and the resulting mixture was partitioned. The
organic layer was washed with brine, dried (Na2SO4), and evaporated.
The residue was purified by silica gel column chromatography (Et2O/
hexane, 1:50) to give 16 (7.73 g, 30%) as an oil: 1H NMR (270 MHz,
CDCl3) δ 7.73-7.35 (m, 10 H), 6.98 (ddd, 1 H, J ) 15.8, 3.3, 3.3
Hz), 6.26 (ddd, 1 H, J ) 15.8, 2.6, 2.0 Hz), 4.34 (dd, 2 H, J ) 3.3, 2.0
Hz), 4.22 (q, 2 H, J ) 7.3), 1.31 (t, 3 H, J ) 7.3 Hz), 1.08 (s, 9 H).
(()-trans-4-(tert-Butyldiphenylsilyloxy)-2-butenol (17). To a solu-
tion of 16 (2.06 g, 5.59 mmol) in THF (20 mL) was added slowly
Radical Reactions of 8a and Purification of the Products 9a, 9b,
10a, and 10b. To a solution of 8a (220 mg, 0.51 mmol) in benzene
(50 mL) at 80 °C was added a solution of Bu3SnH (200 µL, 0.74 mmol)
and AIBN (50 mg, 0.30 mmol) in benzene (10 mL) slowly over a 4 h
period. The solvent was evaporated, and the residue was purified by